Campaign details
Brand: AstraZeneca Brand owner: AstraZeneca Entrant company: EdelmanIdea creation: Edelman New York Market: United States Sector: Pharma & healthcare (general) Media channels: Newspapers, Search marketing, Social media, Word of mouth, Influencers, KOLs, Outdoor, Out-of-home, Online video, Magazines - consumer, Radio & audio, Websites & micrositesBudget: Over 20 million
Executive summary
AstraZeneca makes EVUSHELD, the world’s first long-acting monoclonal antibody authorized as supplemental COVID-19 protection for seven million Americans who are immunocompromised due to disease or medication.
The immunocompromised are neither adequately protected...